Lerato Mbele speaks to Dr Katherine Gill, a Clinical Research Lead at the Desmond Tutu Health Foundation about South Africa and Uganda's clinical trials which have shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other pre-exposure drugs, both daily pills.

<p>Lerato Mbele speaks to Dr Katherine Gill, a Clinical Research Lead at the Desmond Tutu Health Foundation about South Africa and Uganda's clinical trials which have shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other pre-exposure drugs, both daily pills.</p>

POWER Talk is a mid-morning talk show programme, hosted by Lerato Mbele. The show delves deeper into the news of the day along with larger societal themes, inviting listeners to help unpack issues on the day’s current affairs agenda and topics close to their hearts. Mbele also interviews the biggest newsmakers and experts in South Africa, helping listeners makes sense of their world.

<p>POWER Talk is a mid-morning talk show programme, hosted by Lerato Mbele. The show delves deeper into the news of the day along with larger societal themes, inviting listeners to help unpack issues on the day’s current affairs agenda and topics close to their hearts. Mbele also interviews the biggest newsmakers and experts in South Africa, helping listeners makes sense of their world.</p>

Advertisement